RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Paradigm Biopharmaceuticals Stock

Paradigm Biopharmaceuticals Liabilities 2025

Paradigm Biopharmaceuticals Liabilities

3.39 M AUD

Ticker

PAR.AX

ISIN

AU000000PAR5

In 2025, Paradigm Biopharmaceuticals's total liabilities amounted to 3.39 M AUD, a -74.7% difference from the 13.39 M AUD total liabilities in the previous year.

Paradigm Biopharmaceuticals Aktienanalyse

What does Paradigm Biopharmaceuticals do?

Paradigm Biopharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Paradigm Biopharmaceuticals's Liabilities

Paradigm Biopharmaceuticals's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Paradigm Biopharmaceuticals's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Paradigm Biopharmaceuticals's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Paradigm Biopharmaceuticals's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Paradigm Biopharmaceuticals’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Paradigm Biopharmaceuticals stock

What is the level of liabilities of Paradigm Biopharmaceuticals this year?

Paradigm Biopharmaceuticals has a debt balance of 3.39 M AUD this year.

What were the liabilities of Paradigm Biopharmaceuticals compared to the previous year?

The liabilities of Paradigm Biopharmaceuticals have increased by -74.7% dropped compared to the previous year.

What are the consequences of high debt for investors of Paradigm Biopharmaceuticals?

High liabilities can pose a risk for investors of Paradigm Biopharmaceuticals, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Paradigm Biopharmaceuticals?

Low liabilities mean that Paradigm Biopharmaceuticals has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Paradigm Biopharmaceuticals affect the company?

An increase in liabilities of Paradigm Biopharmaceuticals can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Paradigm Biopharmaceuticals affect the company?

A decrease in the liabilities of Paradigm Biopharmaceuticals can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Paradigm Biopharmaceuticals?

Some factors that can influence the liabilities of Paradigm Biopharmaceuticals include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Paradigm Biopharmaceuticals so important for investors?

The liabilities of Paradigm Biopharmaceuticals are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Paradigm Biopharmaceuticals take to modify the liabilities?

To change its liabilities, Paradigm Biopharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Paradigm Biopharmaceuticals pay?

Over the past 12 months, Paradigm Biopharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Paradigm Biopharmaceuticals is expected to pay a dividend of 0 AUD.

What is the dividend yield of Paradigm Biopharmaceuticals?

The current dividend yield of Paradigm Biopharmaceuticals is .

When does Paradigm Biopharmaceuticals pay dividends?

Paradigm Biopharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Paradigm Biopharmaceuticals?

Paradigm Biopharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Paradigm Biopharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Paradigm Biopharmaceuticals located?

Paradigm Biopharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Paradigm Biopharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Paradigm Biopharmaceuticals from 10/6/2025 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 10/6/2025.

When did Paradigm Biopharmaceuticals pay the last dividend?

The last dividend was paid out on 10/6/2025.

What was the dividend of Paradigm Biopharmaceuticals in the year 2024?

In the year 2024, Paradigm Biopharmaceuticals distributed 0 AUD as dividends.

In which currency does Paradigm Biopharmaceuticals pay out the dividend?

The dividends of Paradigm Biopharmaceuticals are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Paradigm Biopharmaceuticals

Our stock analysis for Paradigm Biopharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Paradigm Biopharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.